Korean startup Mediver, specializing in medical and beauty devices, has secured a pre-Series A investment of 1.5 billion KRW. This funding round included participation from two investors, including Daekyo Investment. Mediver was highly rated for its market competitiveness and growth potential, thanks to its comprehensive product portfolio and foundational technologies spanning medical devices, skin beauty devices, and electronic drugs. The company offers a diverse range of products, including skin lasers, radiofrequency (RF) devices, ultrasound (HIFU) equipment, and medical devices for managing chronic and intractable pain. Recently, Mediver has been strengthening its global business partnerships to target overseas markets in North America, Europe, and Latin America.

Facing intense competition in the domestic beauty medical device market, Mediver is focusing on expanding its sales by targeting overseas markets such as Japan, Vietnam, Taiwan, and Latin America. The global beauty device market is a high-growth sector, expanding at an annual rate of over 10%.

With this investment, Mediver plans to enhance its product competitiveness by applying and advancing new technologies, such as electronic control technology, and by prioritizing customer convenience in design.

Bumjun Kim, Director at Daekyo Investment, said, “We have consistently been interested in the medical and beauty device sector and have been discovering companies in this field. Through joint investments with our existing portfolio companies, we have established a comprehensive portfolio in the beauty device sector, covering manufacturing, distribution, sales, and pain management.”

Kyu-uk Lee, Deputy CEO of Mediver, stated, “We will aggressively pursue overseas market expansion by strengthening international certifications and forming global business partnerships. We particularly plan to aggressively expand into Southeast Asia and North America.”